2011 Summit: Translational Medicine: Key to Progress or Bridge to Nowhere?, Andrew S. Grove, PhD – Video
By daniellenierenberg
Andy Grove, PhD and Former CEO of Intel Corporation, dared to suggest that translational medicine will be a "bridge to nowhere" if the way we handle the development of new drugs does not undergo a serious transformation. He proposed a radical rethinking of our whole regulatory and IP system, encouraging all members of the stem cell community to stimulate action and push for change.
See the original post:
2011 Summit: Translational Medicine: Key to Progress or Bridge to Nowhere?, Andrew S. Grove, PhD - Video
Uncategorized
Comments Off on 2011 Summit: Translational Medicine: Key to Progress or Bridge to Nowhere?, Andrew S. Grove, PhD – Video |
December 14th, 2011
This author published 4793 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research